The Key Importance of Screening Underprivileged People in Order to Achieve Global Hepatitis Virus Elimination Targets

Viruses, Journal Year: 2025, Volume and Issue: 17(2), P. 265 - 265

Published: Feb. 14, 2025

Chronic hepatitis B (HBV), alongside D virus (HDV) super-/co-infection and chronic C (HCV), are major contributors to cirrhosis, end-stage liver disease, hepatocellular carcinoma (HCC), liver-related mortality. Despite significant progress in antiviral treatments HBV vaccination, viral remains a global health burden. Vulnerable populations, such as those experiencing homelessness, migrants, economically disadvantaged groups, disproportionately impacted by these infections, often facing barriers care exclusion from traditional systems. This leads undiagnosed cases ongoing transmission, undermining efforts eliminate HCV 2030, outlined the World Health Organization (WHO). Recent studies highlight importance of tailored interventions address inequalities. For instance, on-site community-based screening initiatives targeting marginalized groups have shown promise, achieving higher linkage rates without monetary incentives. These approaches not only enhance diagnosis but also facilitate integration into healthcare systems, addressing both public social disparities. review underscores need for targeted strategies promote early detection management underserved populations. Such critical advancing WHO's elimination goals, improving outcomes, broader determinants health.

Language: Английский

Bridging the gap: advancing health equity and eliminating HBV and HCV among marginalized populations

The Lancet Regional Health - Europe, Journal Year: 2025, Volume and Issue: 49, P. 101222 - 101222

Published: Jan. 21, 2025

Language: Английский